Literature DB >> 23824908

Prostate cancer screening: a complicated puzzle, explanation needed.

Barak Gaster1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23824908      PMCID： PMC3832726          DOI： 10.1007/s11606-013-2542-x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  8 in total

Review 1.  Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force.

Authors:  Roger Chou; Jennifer M Croswell; Tracy Dana; Christina Bougatsos; Ian Blazina; Rongwei Fu; Ken Gleitsmann; Helen C Koenig; Clarence Lam; Ashley Maltz; J Bruin Rugge; Kenneth Lin
Journal:  Ann Intern Med       Date:  2011-10-07       Impact factor: 25.391

2.  Quality-of-life effects of prostate-specific antigen screening.

Authors:  Eveline A M Heijnsdijk; Elisabeth M Wever; Anssi Auvinen; Jonas Hugosson; Stefano Ciatto; Vera Nelen; Maciej Kwiatkowski; Arnauld Villers; Alvaro Páez; Sue M Moss; Marco Zappa; Teuvo L J Tammela; Tuukka Mäkinen; Sigrid Carlsson; Ida J Korfage; Marie-Louise Essink-Bot; Suzie J Otto; Gerrit Draisma; Chris H Bangma; Monique J Roobol; Fritz H Schröder; Harry J de Koning
Journal:  N Engl J Med       Date:  2012-08-16       Impact factor: 91.245

3.  Cancer statistics, 2012.

Authors:  Rebecca Siegel; Deepa Naishadham; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2012-01-04       Impact factor: 508.702

4.  Prostate-cancer mortality at 11 years of follow-up.

Authors:  Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Stefano Ciatto; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Hans Lilja; Marco Zappa; Louis J Denis; Franz Recker; Alvaro Páez; Liisa Määttänen; Chris H Bangma; Gunnar Aus; Sigrid Carlsson; Arnauld Villers; Xavier Rebillard; Theodorus van der Kwast; Paula M Kujala; Bert G Blijenberg; Ulf-Hakan Stenman; Andreas Huber; Kimmo Taari; Matti Hakama; Sue M Moss; Harry J de Koning; Anssi Auvinen
Journal:  N Engl J Med       Date:  2012-03-15       Impact factor: 91.245

5.  Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.

Authors:  Gerald L Andriole; E David Crawford; Robert L Grubb; Saundra S Buys; David Chia; Timothy R Church; Mona N Fouad; Claudine Isaacs; Paul A Kvale; Douglas J Reding; Joel L Weissfeld; Lance A Yokochi; Barbara O'Brien; Lawrence R Ragard; Jonathan D Clapp; Joshua M Rathmell; Thomas L Riley; Ann W Hsing; Grant Izmirlian; Paul F Pinsky; Barnett S Kramer; Anthony B Miller; John K Gohagan; Philip C Prorok
Journal:  J Natl Cancer Inst       Date:  2012-01-06       Impact factor: 13.506

6.  Quality of life and satisfaction with outcome among prostate-cancer survivors.

Authors:  Martin G Sanda; Rodney L Dunn; Jeff Michalski; Howard M Sandler; Laurel Northouse; Larry Hembroff; Xihong Lin; Thomas K Greenfield; Mark S Litwin; Christopher S Saigal; Arul Mahadevan; Eric Klein; Adam Kibel; Louis L Pisters; Deborah Kuban; Irving Kaplan; David Wood; Jay Ciezki; Nikhil Shah; John T Wei
Journal:  N Engl J Med       Date:  2008-03-20       Impact factor: 91.245

7.  Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.

Authors:  Amir Qaseem; Michael J Barry; Thomas D Denberg; Douglas K Owens; Paul Shekelle
Journal:  Ann Intern Med       Date:  2013-05-21       Impact factor: 25.391

8.  Primary care physicians' reported use of pre-screening discussions for prostate cancer screening: a cross-sectional survey.

Authors:  Suzanne K Linder; Sarah T Hawley; Crystale P Cooper; Lawrence E Scholl; Maria Jibaja-Weiss; Robert J Volk
Journal:  BMC Fam Pract       Date:  2009-03-18       Impact factor: 2.497
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.